$OVN:ASX - OVENTUS MEDICAL - Breakout on FDA approval granted

I'm quite late to the party on this one as it is already up 12% on the news of FDA approval being granted. My thinking is that it has been around 30% higher previously so there could still be more upside to this stock as more news services pick up and distribute the announcement. From a business perspective as things like obesity rates increase there will be more and more people with interrupted sleep as well as snorers with partners willing to smother them in their sleep. Morningstar Quant valuations put it above 55 cents which is somewhat reassuring as well. Could be worth a watch...

Oventus Medical Limited is an Australia-based medical device company that is commercializing a suite of oral appliances for the treatment of sleep apnea and snoring. The principal activities of the Company consist of the commercialization and distribution of the O2Vent Mono in Australia, as well as development of a pipeline or products to treat segments of the snoring and sleep and apnea market. These segments include those that do not comply or adhere to existing treatment options due to nasal obstruction and/or inability to utilize the continuous positive airway pressure (CPAP) mask. Its devices have an airway within the device that delivers air to the back of the mouth bypassing multiple obstructions from the nose, soft palate and tongue. The O2Vent is designed to allow nasal breathing when the nose is unobstructed. It uses three-dimensional (3D) metal printing technologies to manufacture medical devices for the treatment of sleep apnea.